Search company, investor...

ELEX

elextec.com

Founded Year

2009

Stage

Series D | Alive

Total Raised

$82.38M

Last Raised

$56.11M | 2 yrs ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+20 points in the past 30 days

About ELEX

ELEX specializes in network information security products and solutions.

Headquarters Location

4-5/F, Building C, 168 Software Ave. Yuhuatai District

Nanjing, Jiangsu, 210012,

China

(+86) 025-8673 8863

Missing: ELEX's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ELEX's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing ELEX

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ELEX is included in 1 Expert Collection, including Cybersecurity.

C

Cybersecurity

4,937 items

ELEX Patents

ELEX has filed 1 patent.

The 3 most popular patent topics include:

  • Amines
  • Calcium channel blockers
  • Cardiac arrhythmia
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/28/2019

8/30/2022

Cardiac arrhythmia, Ion channels, Calcium channel blockers, Prodrugs, Amines

Grant

Application Date

3/28/2019

Grant Date

8/30/2022

Title

Related Topics

Cardiac arrhythmia, Ion channels, Calcium channel blockers, Prodrugs, Amines

Status

Grant

Latest ELEX News

Embracer lost $431 million last year

May 19, 2022

Publisher posts soaring revenues on acquisitions but says it doesn't need to buy more companies to grow; Elex 2 disappoints Embracer Group today reported its financial results for its fourth quarter and full fiscal year, showing that its string of high-profile acquisitions helped push net revenues higher, but did not have the same effect on the bottom line. For the quarter ended March 31, Embracer reported net sales up 117% to SEK 5.23 billion ($525 million), but a loss of SEK 1.67 billion ($168 million), compared to the previous fourth quarter's profit of SEK 159m ($16 million). The sales gains were driven by acquisitions like Gearbox, Easybrain, and Asmodee, as Embracer reported organic growth of negative 34% for the quarter. It blamed that number on a tough comparison from the previous year, when its Coffee Stain Publishing division had a breakthrough hit with Valheim. Revenues from Coffee Stain sank 78% year-over-year for the quarter, from SEK 781 million ($78.5 million) to SEK 171 million ($17.2 million). While the scope of Valheim's success was unexpected, Embracer CEO Lars Wingefors believed the phenomenon is repeatable, saying, "We hope and believe we have many more of those successes in the pipeline in the year to come." Beyond that, the company also said the fourth quarter's biggest release, THQ Nordic's open-world RPG Elex 2, did not live up to financial expectations, although it believes it will provide a positive return on investment eventually. Elex 2 is off to a disappointing start For the full year, Embracer reported net sales up 89% to SEK 17 billion ($1.71 billion), with post-tax losses of SEK 4.29 billion ($431 million), compared to a profit of SEK 287 million ($28.9 million) last year. The sales gains were again the result of acquisitions, as organic growth for the full year in constant currency was negative 7%. "Our growth model is unchanged," Wingefors said. "Our main priority across all operative groups is to achieve profitable organic growth." Wingefors painted the company's 2021/2022 as a transition year, where the company was putting more money into its development pipeline but relatively few of those titles had been released and given a chance to earn back that investment. Embracer expects to post "substantial" organic growth this year. "The first major AAA release, which is expected to step change the pace of organic growth, is the much-anticipated reboot of Saints Row scheduled for release on August 23," Wingefors said. "Across 20 publishers, we have a vast and diversified pipeline of upcoming premium PC- and console games with 223 games to be released in the coming years, including more than 25 AAA games up until FY 25/26." Wingefors also signaled a possible change to Embracer's acquisition strategy, while still leaving room for further purchases. "Needless to say, we do not need to make any further acquisitions to grow," he said. "Nevertheless, we continue to scout for selected additional M&A opportunities to support our long-term growth ambitions. We have an exciting funnel of targets, with emphasis on bolt on acquisitions within existing operative groups." He also added that the company has noticed "a notable correction in valuation expectations in the private M&A market" in recent months. Sign up for The Publishing & Retail newsletter and get the best of GamesIndustry.biz in your inbox. Enter your email address

ELEX Frequently Asked Questions (FAQ)

  • When was ELEX founded?

    ELEX was founded in 2009.

  • Where is ELEX's headquarters?

    ELEX's headquarters is located at 4-5/F, Building C, 168 Software Ave., Nanjing.

  • What is ELEX's latest funding round?

    ELEX's latest funding round is Series D.

  • How much did ELEX raise?

    ELEX raised a total of $82.38M.

  • Who are the investors of ELEX?

    Investors of ELEX include Sinolink Securities Co., Jinguan Investment, Shanghai Hengji Puye Assets Management, Taizhou Financial Investment Group, Baoding Invest and 15 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.